The US will begin sharing its entire stock of AstraZeneca COVID-19 vaccines with the world once it clears federal safety reviews, the White House said on Monday.
The State Department on Monday urged Americans reconsider any international travel they may have planned and said it would issue specific warnings not to visit roughly 80 per cent of the world’s countries.
A rare, rogue immune response is the main suspect as authorities investigate highly unusual blood clots following use of two similar COVID-19 vaccines from Johnson & Johnson and AstraZeneca.
Dozens of Americans are rolling up their sleeves for a third dose of COVID-19 vaccine - this time, shots tweaked to guard against a worrisome mutated version of the virus.
One year after the nation was brought to a near-standstill by the coronavirus, President Joe Biden pledged in his first prime-time address on Thursday night to make all adults eligible for vaccines by May 1.
1730735572_80X80.jpg)
